Anna La Salvia

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues

Sara Pusceddu, Claudio Vernieri, Massimo Di Maïo et al. · Gastroenterology · 2018 · 89 citations · Full text

Medicine, Endocrinology, Oncology +11

The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications

Beatriz Soldevilla, Carlos Carretero-Puche, Gonzalo Goméz-López et al. · European Journal of Cancer · 2019 · 83 citations · Full text

Medicine, Immunology, Oncology +17

High interlaboratory and interobserver agreement of somatostatin receptor immunohistochemical determination and correlation with response to somatostatin analogs

Atsuko Kasajima, Mauro Papotti, Wataru Ito et al. · Human Pathology · 2017 · 45 citations

Medicine, Endocrinology, Pharmacology +8

Treatment of Patients With Metastatic Colorectal Cancer in a Real-World Scenario: Probability of Receiving Second and Further Lines of Therapy and Description of Clinical Benefit

Marco Tampellini, Massimo Di Maïo, Chiara Baratelli et al. · Clinical Colorectal Cancer · 2017 · 41 citations · Full text

Medicine, Oncology, Surgery +13

Nonconventional Doses of Somatostatin Analogs in Patients With Progressing Well-Differentiated Neuroendocrine Tumor

Giuseppe Lamberti, Antongiulio Faggiano, Nicole Brighi et al. · The Journal of Clinical Endocrinology & Metabolism · 2019 · 41 citations · Full text

Medicine, Oncology, Pharmacology +16